Moneycontrol
HomeNewsBusinessReal EstateExplainer | FM’s ‘no fresh insolvency’ offer comforts builders, but what about homebuyers?
Trending Topics

Explainer | FM’s ‘no fresh insolvency’ offer comforts builders, but what about homebuyers?

Measure does little to boost housing sales and may curtail remedies available to homebuyers, say legal experts

May 19, 2020 / 07:55 IST
Story continues below Advertisement
Representative Image

In a bid to grant relief to companies defaulting on loans due to the COVID-19 stress, Finance Minister Nirmala Sitharaman said on May 17 that no fresh insolvency would be initiated for one year under the Insolvency and Bankruptcy Code (IBC) and that coronavirus-related debt would be excluded from definition of default. While these measures seek to offer a breathing space to real estate companies to recover, they may curtail remedies available to homebuyers, say experts.

These measures were announced by Sitharaman as part of the fifth and final tranche of the Rs 20-lakh crore stimulus package unveiled to boost the economy ravaged by the pandemic and subsequent lockdown. The FM also said that an ordinance would be promulgated to bring this change in IBC.

Story continues below Advertisement

Under the IBC that provides for a time-bound and market-linked resolution of stressed assets, an entity can seek insolvency proceedings against a company even if the default is only for a day. In March, the government raised the threshold default amount for invoking insolvency proceedings under IBC to Rs 1 crore from Rs 1 lakh in order to prevent triggering of such proceedings against small and medium enterprises.

 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show